We are an independent biotech company based in Ticino. We focus on generation, development and characterization of nanobodies produced from proprietary, rationally engineered human libraries relevant to enhance the R&D pipeline of partners and clients.
Some insights
CLB was founded by scientists trained at Cambridge and Stanford with publications on the most prestigious scientific journals. Our mission is pre-clinical R&D through antibody discovery, development and engineering, expanding the R&D pipelines of partnering pharma companies with nanobodies libraries.